112 related articles for article (PubMed ID: 9657480)
1. Images in cardiovascular medicine. Metabolic imaging identifies non-Hodgkin's lymphoma infiltrating heart.
Römer W; Garbrecht M; Fuchs C; Schwaiger M
Circulation; 1998 Jun; 97(25):2577-8. PubMed ID: 9657480
[No Abstract] [Full Text] [Related]
2. Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
Nguyen JD; Carrasquillo JA; Little RF; Ryan QC; Wilson W; Chen CC
Clin Nucl Med; 2003 Dec; 28(12):979-80. PubMed ID: 14663321
[No Abstract] [Full Text] [Related]
3. Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.
Mehta A; Muthukrishnan A
Hell J Nucl Med; 2011; 14(2):186-7. PubMed ID: 21761029
[No Abstract] [Full Text] [Related]
4. FDG PET/CT leads to the detection of metastatic involvement of the heart in non-Hodgkin's lymphoma.
Julian A; Wagner T; Ysebaert L; Chabbert V; Payoux P
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1174. PubMed ID: 21431399
[No Abstract] [Full Text] [Related]
5. Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET.
Chamroonrat W; Houseni M; Bing Z; Yang H; Alavi A; Zhuang H
Clin Nucl Med; 2007 Mar; 32(3):252-4. PubMed ID: 17314615
[No Abstract] [Full Text] [Related]
6. False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma.
Yoon SN; Park CH; Kim MK; Hwang KH; Kim S
Clin Nucl Med; 2001 May; 26(5):461-2. PubMed ID: 11317035
[No Abstract] [Full Text] [Related]
7. Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma.
Naumann R; Beuthien-Baumann B
Clin Lymphoma; 2003 Jun; 4(1):50-1. PubMed ID: 12837155
[No Abstract] [Full Text] [Related]
8. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
[No Abstract] [Full Text] [Related]
9. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
11. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.
Torizuka T; Nakamura F; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Kobayashi M; Ouchi Y
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):22-8. PubMed ID: 14574514
[TBL] [Abstract][Full Text] [Related]
12. Novel imaging techniques in NHL: clinical results with PET imaging.
Buchmann I; Reske SN
Ann Hematol; 2001; 80 Suppl 3():B54-7. PubMed ID: 11757709
[No Abstract] [Full Text] [Related]
13. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
Spaepen K; Mortelmans L
Q J Nucl Med; 2001 Sep; 45(3):269-73. PubMed ID: 11788819
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
Juweid ME
J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
[No Abstract] [Full Text] [Related]
16. Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancer.
Ghesani NV; Sun X; Zhuang H; Sam JW; Alavi A
Clin Nucl Med; 2003 Aug; 28(8):666-7. PubMed ID: 12897654
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
18. Peripheral nerves and muscles involvement by non-Hodgkin's lymphoma seen on FDG PET/CT scan.
Shah HJ; Lele VR; Keraliya AR; Aland PS
Neurol India; 2014; 62(1):83-5. PubMed ID: 24608470
[No Abstract] [Full Text] [Related]
19. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
Chiusolo P; Sica S; Leone G
Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
[TBL] [Abstract][Full Text] [Related]
20. [Malignant non-Hodgkin's lymphoma revealed by cardiac involvement. Apropos of a case].
Nazzi M; Khatouri A; Zbir E; al Bouzidi A; Kendoussi M; Benomar S; Hamani A
Med Trop (Mars); 1994; 54(3):279-80. PubMed ID: 7885215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
